PAPI, Alberto
 Distribuzione geografica
Continente #
NA - Nord America 3795
EU - Europa 1985
AS - Asia 1305
OC - Oceania 165
AF - Africa 75
SA - Sud America 63
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7389
Nazione #
US - Stati Uniti d'America 3651
CN - Cina 432
GB - Regno Unito 401
IT - Italia 375
SE - Svezia 342
JP - Giappone 188
DE - Germania 138
ES - Italia 131
AU - Australia 128
IN - India 119
CA - Canada 118
NL - Olanda 118
VN - Vietnam 113
TW - Taiwan 90
HK - Hong Kong 66
FR - Francia 64
CZ - Repubblica Ceca 55
RU - Federazione Russa 51
KR - Corea 42
ID - Indonesia 40
PL - Polonia 40
IE - Irlanda 39
NZ - Nuova Zelanda 37
TH - Thailandia 36
PT - Portogallo 34
RO - Romania 28
ZA - Sudafrica 27
TR - Turchia 26
IR - Iran 24
SK - Slovacchia (Repubblica Slovacca) 22
CO - Colombia 21
GR - Grecia 21
MX - Messico 21
SG - Singapore 21
BE - Belgio 19
PH - Filippine 19
CH - Svizzera 18
EG - Egitto 18
PK - Pakistan 18
BR - Brasile 17
MY - Malesia 15
RS - Serbia 13
UA - Ucraina 13
IL - Israele 11
MK - Macedonia 11
SA - Arabia Saudita 11
BG - Bulgaria 10
CL - Cile 10
PE - Perù 8
DZ - Algeria 6
HU - Ungheria 6
UZ - Uzbekistan 6
DK - Danimarca 5
HR - Croazia 5
KE - Kenya 5
LT - Lituania 5
AT - Austria 4
FI - Finlandia 4
KW - Kuwait 4
BD - Bangladesh 3
CR - Costa Rica 3
EC - Ecuador 3
KZ - Kazakistan 3
MT - Malta 3
NO - Norvegia 3
QA - Qatar 3
TN - Tunisia 3
BA - Bosnia-Erzegovina 2
CM - Camerun 2
ET - Etiopia 2
IQ - Iraq 2
LB - Libano 2
LY - Libia 2
NG - Nigeria 2
SC - Seychelles 2
SI - Slovenia 2
SR - Suriname 2
SY - Repubblica araba siriana 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
BO - Bolivia 1
BT - Bhutan 1
BY - Bielorussia 1
CD - Congo 1
CU - Cuba 1
DO - Repubblica Dominicana 1
EU - Europa 1
JE - Jersey 1
JO - Giordania 1
KH - Cambogia 1
LK - Sri Lanka 1
LV - Lettonia 1
MA - Marocco 1
MO - Macao, regione amministrativa speciale della Cina 1
NP - Nepal 1
OM - Oman 1
PS - Palestinian Territory 1
RW - Ruanda 1
SD - Sudan 1
TZ - Tanzania 1
Totale 7388
Città #
Santa Cruz 664
Stockholm 258
Fairfield 252
Des Moines 174
Houston 174
Woodbridge 133
Seattle 128
Ashburn 124
Dong Ket 98
Ann Arbor 96
Buffalo 94
Cambridge 77
Taipei 70
Ferrara 65
Wilmington 62
Chicago 59
Shanghai 59
San Diego 58
Hebei 50
Beijing 44
Central 43
Guangzhou 41
London 38
Los Angeles 36
Barcelona 34
Utrecht 34
Dublin 31
Toronto 31
New York 30
Las Vegas 29
Madrid 29
Tokyo 29
Warsaw 29
Cardiff 26
Dallas 22
Lake Forest 22
Sydney 22
Nanjing 21
Saint Petersburg 21
Birmingham 20
Bratislava 19
Auckland 18
Wuhan 17
Provo 16
Boardman 15
Henderson 15
Melbourne 15
San Francisco 15
Seoul 15
Hangzhou 14
Manchester 14
Singapore 14
Brooklyn 13
Duncan 13
Hyderabad 13
Milford Haven 13
Paris 13
Chengdu 12
Fleming Island 12
Karlstad 12
Shenyang 12
Central District 11
Hangyang 11
Hanoi 11
Milan 11
Munich 11
Ottawa 11
Padova 11
Auburn 10
Bangkok 10
Clearwater 10
Hamburg 10
Rome 10
Songkhla 10
Winnipeg 10
Atlanta 9
Bengaluru 9
Brisbane 9
Brookings 9
Changsha 9
Dehradun 9
Istanbul 9
Regensburg 9
Southampton 9
Bogotá 8
Bologna 8
Boston 8
Chiyoda-ku 8
Council Bluffs 8
Huntsville 8
Imola 8
Middletown 8
Muizenberg 8
Mumbai 8
Oxford 8
Rotterdam 8
Scranton 8
Silverton 8
Alcanena 7
Alexandria 7
Totale 3981
Nome #
Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial, file e309ade2-d568-3969-e053-3a05fe0a2c94 978
Exploring the relevance and extent of small airways dysfunction in asthma (ATLANTIS): baseline data from a prospective cohort study, file e309ade3-b15a-3969-e053-3a05fe0a2c94 879
Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial, file e309ade2-d573-3969-e053-3a05fe0a2c94 681
Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): a double-blind, randomised, phase 3A trial, file e309ade4-becd-3969-e053-3a05fe0a2c94 354
Regular versus as-needed budesonide and formoterol combination treatment for moderate asthma: a non-inferiority, randomised, double-blind clinical trial, file e309ade2-d388-3969-e053-3a05fe0a2c94 196
Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management, file e309ade3-e7e4-3969-e053-3a05fe0a2c94 141
Controlled trial of budesonide-formoterol as needed for mild asthma, file e309ade2-cf33-3969-e053-3a05fe0a2c94 133
Relationship of Inhaled Corticosteroid Adherence to Asthma Exacerbations in Patients with Moderate-to-Severe Asthma, file e309ade4-7604-3969-e053-3a05fe0a2c94 131
Single inhaler extrafine triple therapy in uncontrolled asthma (TRIMARAN and TRIGGER): two double-blind, parallel-group, randomised, controlled phase 3 trials, file e309ade4-7f67-3969-e053-3a05fe0a2c94 120
Extrafine triple therapy in patients with asthma and persistent airflow limitation, file e309ade4-6f73-3969-e053-3a05fe0a2c94 97
Th2 cytokines impair innate immune responses to rhinovirus in respiratory epithelial cells, file e309ade2-d027-3969-e053-3a05fe0a2c94 93
Inhaled corticosteroids in COPD: Friend or foe?, file e309ade3-49d4-3969-e053-3a05fe0a2c94 89
Efficacy and Safety of treatment with dupilumab for severe asthma: a systematic review of the EAACI guidelines-Recommendations on the use of biologicals in severe asthma, file e309ade4-6c79-3969-e053-3a05fe0a2c94 85
Use of mucolytics in COPD: A Delphi consensus study, file e309ade4-cb1f-3969-e053-3a05fe0a2c94 82
Severe pneumonia after intravesical BCG instillation in a patient with invasive bladder cancer: case report and literature review, file e309ade2-c7fc-3969-e053-3a05fe0a2c94 81
Real-World Experience with Dupilumab in Severe Asthma: One-Year Data from an Italian Named Patient Program, file e309ade4-6bfc-3969-e053-3a05fe0a2c94 72
ICS-formoterol reliever therapy stepwise treatment algorithm for adult asthma, file e309ade4-8db0-3969-e053-3a05fe0a2c94 72
Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD, file e309ade2-d1c5-3969-e053-3a05fe0a2c94 70
Phospho-p38 MAPK expression in COPD patients and asthmatics and in challenged bronchial epithelium, file e309ade4-b8c5-3969-e053-3a05fe0a2c94 69
Benralizumab for the prevention of COPD exacerbations, file e309ade4-cd8f-3969-e053-3a05fe0a2c94 63
Burden of Pertussis in COPD: A Retrospective Database Study in England, file e309ade4-4eff-3969-e053-3a05fe0a2c94 60
Predicting response to benralizumab in chronic obstructive pulmonary disease: analyses of GALATHEA and TERRANOVA studies, file e309ade4-a288-3969-e053-3a05fe0a2c94 59
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma, file e309ade4-c029-3969-e053-3a05fe0a2c94 58
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: a systematic review for the EAACI guidelines - recommendations on the use of biologicals in severe asthma, file e309ade4-8b10-3969-e053-3a05fe0a2c94 57
Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline, file e309ade3-b15e-3969-e053-3a05fe0a2c94 55
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019, file e309ade3-f58a-3969-e053-3a05fe0a2c94 52
An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease, file e309ade2-d56b-3969-e053-3a05fe0a2c94 51
SABINA: An Overview of Short-Acting β2-Agonist Use in Asthma in European Countries, file e309ade4-72bb-3969-e053-3a05fe0a2c94 49
Extrafine triple therapy in patients with symptomatic COPD and history of one moderate exacerbation, file e309ade3-4251-3969-e053-3a05fe0a2c94 48
IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesis, file e309ade4-9727-3969-e053-3a05fe0a2c94 48
Primary pulmonary epithelioid hemangioendothelioma: A rare cause of PET-negative pulmonary nodules, file e309ade4-c4b7-3969-e053-3a05fe0a2c94 47
Interleukin-13 and-4 expression in the central airways of smokers with chronic bronchitis, file e309ade0-2ded-3969-e053-3a05fe0a2c94 46
Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal, file e309ade4-aef3-3969-e053-3a05fe0a2c94 46
COPD increases the risk of squamous histological subtype in smokers who develop non-small cell lung carcinoma, file e309ade0-2dec-3969-e053-3a05fe0a2c94 44
Efficacy and safety of single-inhaler extrafine triple therapy versus inhaled corticosteroid plus long-acting beta2 agonist in eastern Asian patients with COPD: the TRIVERSYTI randomised controlled trial, file e309ade4-8490-3969-e053-3a05fe0a2c94 44
Bronchial mucosal IFN-α/β and pattern recognition receptor expression in patients with experimental rhinovirus-induced asthma exacerbations, file e309ade2-b996-3969-e053-3a05fe0a2c94 43
TGF-β Signaling Pathways in Different Compartments of the Lower Airways of Patients With Stable COPD, file e309ade3-480e-3969-e053-3a05fe0a2c94 43
Extrafine triple therapy delays COPD clinically important deterioration vs ICS/LABA, LAMA, or LABA/LAMA, file e309ade4-a3f6-3969-e053-3a05fe0a2c94 43
Efficacy and safety of two doses of budesonide/formoterol fumarate metered dose inhaler in COPD, file e309ade4-afe4-3969-e053-3a05fe0a2c94 43
Eosinophil-derived neurotoxin and clinical outcomes with mepolizumab in severe eosinophilic asthma, file e309ade4-c022-3969-e053-3a05fe0a2c94 43
Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: A randomized noninferiority trial, file e309ade4-1651-3969-e053-3a05fe0a2c94 42
Characteristics of patients making serious inhaler errors with a dry powder inhaler and association with asthma-related events in a primary care setting, file e309ade4-1ae1-3969-e053-3a05fe0a2c94 42
A multinational observational study identifying primary care patients at risk of overestimation of asthma control, file e309ade4-701a-3969-e053-3a05fe0a2c94 42
Prevention of COPD exacerbations: A European Respiratory Society/ American Thoracic Society guideline, file e309ade4-9724-3969-e053-3a05fe0a2c94 42
Inhaled corticosteroid containing combinations and mortality in COPD, file e309ade4-b0ad-3969-e053-3a05fe0a2c94 42
The Hidden Burden of Severe Asthma: From Patient Perspective to New Opportunities for Clinicians, file e309ade4-7fe8-3969-e053-3a05fe0a2c94 41
Asthma COPD Overlap PRO-CON Debate. ACO: The Mistaken Term, file e309ade4-ab4c-3969-e053-3a05fe0a2c94 41
The DisEntangling Chronic Obstructive pulmonary Disease Exacerbations clinical trials NETwork (DECODE-NET): rationale and vision, file e309ade4-bb90-3969-e053-3a05fe0a2c94 41
Diffuse pulmonary meningothelial like nodules simulating metastatic thymoma, file e309ade4-d2a9-3969-e053-3a05fe0a2c94 41
Comorbidities, Cardiovascular Therapies, and COVID-19 Mortality: A Nationwide, Italian Observational Study (ItaliCO), file e309ade4-b409-3969-e053-3a05fe0a2c94 40
Blood eosinophil count and exacerbation risk in patients with COPD, file e309ade4-b54a-3969-e053-3a05fe0a2c94 40
Mepolizumab reduces exacerbations in patients with severe eosinophilic asthma, irrespective of body weight/body mass index: Meta-analysis of MENSA and MUSCA, file e309ade4-9fa8-3969-e053-3a05fe0a2c94 39
Asthma progression and mortality: The role of inhaled corticosteroids, file e309ade4-a2ba-3969-e053-3a05fe0a2c94 39
Moving towards a Treatable Traits model of care for the management of obstructive airways diseases, file e309ade4-f59c-3969-e053-3a05fe0a2c94 39
Treatment strategies for asthma: Reshaping the concept of asthma management, file e309ade4-6b97-3969-e053-3a05fe0a2c94 38
Withdrawal of inhaled corticosteroids versus continuation of triple therapy in patients with COPD in real life: observational comparative effectiveness study, file e309ade4-6f51-3969-e053-3a05fe0a2c94 38
Single-inhaler fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI) triple therapy versus tiotropium monotherapy in patients with COPD, file e309ade4-7ea1-3969-e053-3a05fe0a2c94 38
FN3K expression in COPD: a potential comorbidity factor for cardiovascular disease, file e309ade4-8e73-3969-e053-3a05fe0a2c94 38
Triple therapy in COPD: New evidence with the extrafine fixed combination of beclomethasone dipropionate, formoterol fumarate, and glycopyrronium bromide, file e309ade4-ab2a-3969-e053-3a05fe0a2c94 38
Core outcome set for the management of acute exacerbations of chronic obstructive pulmonary disease: the COS-AECOPD ERS Task Force study protocol, file e309ade4-c46e-3969-e053-3a05fe0a2c94 38
Pharmacokinetics and Safety of Single and Multiple Doses of Oral N-Acetylcysteine in Healthy Chinese and Caucasian Volunteers: An Open-Label, Phase I Clinical Study, file e309ade4-c737-3969-e053-3a05fe0a2c94 38
Extrafine Versus Fine Inhaled Corticosteroids in Relation to Asthma Control: A Systematic Review and Meta-Analysis of Observational Real-Life Studies, file e309ade4-dd19-3969-e053-3a05fe0a2c94 38
Ectopic thymoma simulating a pericardial cyst: case report, file e309ade0-2bea-3969-e053-3a05fe0a2c94 37
An official American Thoracic Society/European Respiratory Society statement: research questions in COPD, file e309ade0-8555-3969-e053-3a05fe0a2c94 37
Molecular testing on bronchial washings for the diagnosis and predictive assessment of lung cancer, file e309ade2-a3c7-3969-e053-3a05fe0a2c94 37
Comparative effectiveness of triple therapy versus dual bronchodilation in COPD, file e309ade2-c7cc-3969-e053-3a05fe0a2c94 37
Determinants of response to inhaled extrafine triple therapy in asthma: analyses of TRIMARAN and TRIGGER, file e309ade4-bb92-3969-e053-3a05fe0a2c94 37
Liberty Asthma QUEST: Phase 3 Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate Dupilumab Efficacy/Safety in Patients with Uncontrolled, Moderate-to-Severe Asthma, file e309ade4-c730-3969-e053-3a05fe0a2c94 37
Identifying Risk of Future Asthma Attacks Using UK Medical Record Data: A Respiratory Effectiveness Group Initiative, file e309ade4-c9c3-3969-e053-3a05fe0a2c94 37
MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): The new generation guideline implementation, file e309ade0-ce14-3969-e053-3a05fe0a2c94 36
Dupilumab Efficacy in Patients Stratified by Baseline Treatment Intensity and Lung Function, file e309ade4-d4a8-3969-e053-3a05fe0a2c94 36
MACVIA clinical decision algorithm in adolescents and adults with allergic rhinitis, file e309ade4-3cc2-3969-e053-3a05fe0a2c94 35
Extrafine beclometasone diproprionate/formoterol fumarate: A review of its effects in chronic obstructive pulmonary disease, file e309ade4-4f05-3969-e053-3a05fe0a2c94 35
Alteration of adenosine receptore in patients with chronic obstructive pulmonary disease, file e309ade4-913f-3969-e053-3a05fe0a2c94 35
ICS/formoterol in the management of asthma in the clinical practice of pulmonologists: an international survey on GINA strategy, file e309ade4-af6d-3969-e053-3a05fe0a2c94 35
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions, file e309ade4-b185-3969-e053-3a05fe0a2c94 35
Over time relationship between platelet reactivity, myocardial injury and mortality in patients with SARS-CoV-2-associated respiratory failure, file e309ade4-d385-3969-e053-3a05fe0a2c94 35
New drugs targeting Th2 lymphocytes in asthma, file e309ade5-0962-3969-e053-3a05fe0a2c94 35
Caring for patients with COPD and COVID-19: a viewpoint to spark discussion, file e309ade4-862b-3969-e053-3a05fe0a2c94 34
A Comparison of the Real-Life Clinical Effectiveness of the Leading Licensed ICS/LABA Combination Inhalers in the Treatment for COPD, file e309ade4-a6ab-3969-e053-3a05fe0a2c94 34
Dose-response relationship of ICS/fast-onset LABA as reliever therapy in asthma, file e309ade5-097b-3969-e053-3a05fe0a2c94 34
Budesonide/formoterol MDI with co-suspension delivery technology in COPD: the TELOS study, file e309ade5-209c-3969-e053-3a05fe0a2c94 34
From Gold 0 to Pre-COPD, file e309ade4-102a-3969-e053-3a05fe0a2c94 33
Risk factors for exacerbations and pneumonia in patients with chronic obstructive pulmonary disease: a pooled analysis, file e309ade4-7f80-3969-e053-3a05fe0a2c94 33
Bronchial mucosal inflammation and illness severity in response to experimental rhinovirus infection in COPD, file e309ade4-a4f5-3969-e053-3a05fe0a2c94 33
The burden of self-reported rhinitis and associated risk for exacerbations with moderate-severe asthma in primary care patients, file e309ade4-a3aa-3969-e053-3a05fe0a2c94 32
Circulating neutrophils levels are a predictor of pneumonia risk in chronic obstructive pulmonary disease, file e309ade4-f6de-3969-e053-3a05fe0a2c94 32
Underuse of spirometry by general practitioners for the diagnosis of COPD in Italy, file e309ade5-0ab3-3969-e053-3a05fe0a2c94 32
Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial, file e309ade4-82cd-3969-e053-3a05fe0a2c94 31
Differential expression of RNA-binding proteins in bronchial epithelium of stable COPD patients, file e309ade4-f573-3969-e053-3a05fe0a2c94 30
Inhaled triple therapy in chronic obstructive pulmonary disease – Authors' reply, file e309ade5-1d96-3969-e053-3a05fe0a2c94 30
Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline, file e309ade3-b15f-3969-e053-3a05fe0a2c94 23
Rhinovirus-induced CCL17 and CCL22 in Asthma Exacerbations and Differential Regulation by STAT6, file 02d33c64-6dec-4ebf-a439-a19c7c98aa43 22
Effects of anti-IL5 biological treatments on blood IgE levels in severe asthmatic patients: A real-life multicentre study (BIONIGE), file 46a8c934-c458-4122-90a9-0ac123b4779c 19
Clinical and Pathologic Factors Predicting Future Asthma in Wheezing Children. A Longitudinal Study, file e309ade4-cd17-3969-e053-3a05fe0a2c94 18
Chronic Obstructive Pulmonary Disease and Ischemic Heart Disease Comorbidity: Overview of Mechanisms and Clinical Management, file e309ade3-e7e5-3969-e053-3a05fe0a2c94 15
A role for phosphoinositol 3-kinase delta in the impairment of glucocorticoid responsiveness in patients with chronic obstructive pulmonary disease, file e309ade2-c13c-3969-e053-3a05fe0a2c94 12
Plasma sRAGE and N-(carboxymethyl) lysine in patients with CHF and/or COPD., file e309ade2-4334-3969-e053-3a05fe0a2c94 11
Rhinovirus Infection Induces Degradation of Antimicrobial Peptides and Secondary Bacterial Infection in Chronic Obstructive Pulmonary Disease, file e309ade0-974b-3969-e053-3a05fe0a2c94 10
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019, file e309ade3-b160-3969-e053-3a05fe0a2c94 10
Totale 7478
Categoria #
all - tutte 13608
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13608

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2017/20181 0000 00 00 0100
2019/20202 1000 10 00 0000
2020/20211268 0007 7088 96102 102169280354
2021/20223307 158160164284 337222 200215 279202723363
2022/20233021 154218721442 201280 324398 283000
Totale 7611